Validity of the Montreal Cognitive Assessment (MoCA) in older adults treated at an outpatient clinic in a hospital in Lima, Peru

Authors

  • Natalie Tinney Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado. Lima, Perú. https://orcid.org/0009-0009-9280-0171
  • Roger Yeremy Tafur Auqui Universidad Peruana de Ciencias Aplicadas, Facultad de Ciencias de la Salud. Lima, Perú. https://orcid.org/0009-0004-8042-853X
  • Gian Franco Jorge Marino Universidad Peruana de Ciencias Aplicadas, Facultad de Ciencias de la Salud. Lima, Perú. https://orcid.org/0009-0006-0124-9707
  • Giovanni Meneses Universidad Nacional Mayor de San Marcos, Facultad de Medicina, Departamento Académico de Medicina Preventiva y Salud Pública. Lima, Perú. https://orcid.org/0000-0003-1677-3457

DOI:

https://doi.org/10.20453/rnp.v88i4.6358

Keywords:

cognitive impairment, elderly, validation

Abstract

Objective: To evaluate the construct validity of the Montreal Cognitive Assessment (MoCA), applied to a Spanish-speaking population. Materials and methods: Transversal, observational and descriptive study of instrument validation. The MoCA, as well as the Mini-Mental Status Examination (MMSE), were applied by three researchers to 110 patients. The internal consistency of the scale was evaluated using Cronbach’s Alpha, and the concordance between researchers, with Cohen’s Kappa coefficient. Sensibility, specificity, positive and negative predictive values, and Spearman’s Rho were calculated to determine the criterion validity, while the construct validity was determined by principal component analysis. Results: 110 patients were studied. Cronbach’s Alpha was 0.89. Weighted Cohen’s Kappa was 0.17 (p = 0.011). The area below the receiver-operator curve was 0.63. Sensibility was 86.2%; specificity, 39.5%; positive predictive value was 33.8%; negative predictive value, 88.9%; quotient of positive probabilities was 1.43, and the quotient of negative probabilities, 0.35. Spearman’s Rho was 0.24. There were 8 factors that explained 65.6% of the variance. Conclusions: The Montreal Cognitive Assessment demonstrates features of validity and reliability to contribute to diagnosis of cognitive decline in the Peruvian population.

Downloads

Download data is not yet available.

Author Biographies

Natalie Tinney, Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado. Lima, Perú.

Universidad Peruana Cayetano Heredia, Facultad de Medicina “Alberto Hurtado”. Bachiller en Medicina, Especialista en Medicina Interna. Hospital San Juan de Lurigancho. Lima, Peru. natalie.tinney.c@upch.pe , ORCID 0009-0009-9280-0171

Roger Yeremy Tafur Auqui, Universidad Peruana de Ciencias Aplicadas, Facultad de Ciencias de la Salud. Lima, Perú.

Universidad Peruana de Ciencias Aplicadas, Facultad de Ciencias de la Salud, Carrera profesional de Medicina. Estudiante de pregrado. Lima, Perú. yeremy2804@hotmail.com ORCID:0009-0004-8042-853X

Gian Franco Jorge Marino, Universidad Peruana de Ciencias Aplicadas, Facultad de Ciencias de la Salud. Lima, Perú.

Universidad Peruana de Ciencias Aplicadas. Facultad de Ciencias de la Salud. Carrera profesional de Medicina. Lima, Perú. Estudiante de pregrado. gianfrancojorgemarino@gmail.com  ORCID:0009-0006-0124-9707

Giovanni Meneses, Universidad Nacional Mayor de San Marcos, Facultad de Medicina, Departamento Académico de Medicina Preventiva y Salud Pública. Lima, Perú.

Universidad Nacional Mayor de San Marcos, Facultad de Medicina, Departamento Académico de Medicina Preventiva y Salud Pública. Doctor en Medicina. Hospital San Juan de Lurigancho, Lima, Perú. gmenesesf@unmsm.edu.pe, ORCID: 0000-0003-1677-3457. 

References

Zurique C, Cadena MO, Zurique M, Camacho PA, Sánchez M, Hernández S, et al. Prevalencia de demencia en adultos mayores de América Latina: revisión sistemática. Rev Esp Geriatr Gerontol [Internet]. 2019; 54(6): 346-355. Disponible en: https://doi.org/10.1016/j.regg.2018.12.007

Custodio N, García A, Montesinos R, Escobar J, Bendezú L. Prevalencia de demencia en una población urbana de Lima-Perú: estudio puerta a puerta. An Fac Med [Internet]. 2008; 69(4): 233-238. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000400003

Instituto Nacional de Salud Mental «Honorio Delgado-Hideyo Noguchi». Estudio epidemiológico de salud mental en Lima Metropolitana y Callao - Replicación 2012. Informe general. An Salud Ment [Internet]. 2013; 29(supl. 1). Disponible en: https://www.insm.gob.pe/investigacion/archivos/estudios/2012%20ASM%20-EESM%20-LM.pdf

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc [Internet]. 2005; 53(4): 695-699. Disponible en: https://doi.org/10.1111/j.1532-5415.2005.53221.x

Maust D, Cristancho M, Gray L, Rushing S, Tjoa C, Thase ME. Chapter 13 - Psychiatric rating scales. En: Aminoff MJ, Boller F, Swaab DF, editores. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2012. pp. 227-237. Disponible en: https://doi.org/10.1016/B978-0-444-52002-9.00013-9

Pinto TC, Machado L, Bulgacov TM, Rodrigues-Júnior AL, Costa ML, Ximenes RC, et al. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD) in the elderly? Int Psychogeriatr [Internet]. 2019; 31(4): 491-504. Disponible en: https://doi.org/10.1017/S1041610218001370

Dong Y, Sharma VK, Chan BP, Venketasubramanian N, Teoh HL, Seong RC, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci [Internet]. 2010; 299(1-2): 15-18. Disponible en: https://doi.org/10.1016/j.jns.2010.08.051

Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington’s disease. Mov Disord [Internet]. 2010; 25(3): 401-404. Disponible en: https://doi.org/10.1002/mds.22748

Guevara-Silva EA. Evaluación de la función cognitiva en pacientes con enfermedad de Parkinson. Diagnóstico [Internet]. 2014; 53(3): 117-122. Disponible en: http://repebis.upch.edu.pe/articulos/diag/v53n3/a2.pdf

Custodio N, Lira D. Adaptación peruana del Minimental State Examination (MMSE). An Fac Med [Internet]. 2014; 75(1): 69. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832014000100012

Pedraza OL, Salazar AM, Sierra FA, Soler D, Castro J, Castillo PC, et al. Confiabilidad, validez de criterio y discriminante del Montreal Cognitive Assessment (MoCA) test, en un grupo de adultos de Bogotá. Acta Med Colomb [Internet]. 2016; 41(4): 221-228. Disponible en: https://doi.org/10.36104/amc.2016.693

Aguilar-Navarro SG, Mimenza-Alvarado AJ, Palacios-García AA, Samudio-Cruz A, Gutiérrez-Gutiérrez LA, Ávila-Funes JA. Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en México. Rev Colomb Psiquiatr [Internet]. 2018; 47(4): 237-243. Disponible en: https://doi.org/10.1016/j.rcp.2017.05.003

Serrano CM, Sorbara M, Minond A, Finlay JB, Arizaga RL, Iturry M, et al. Validation of the Argentine version of the Montreal Cognitive Assessment Test (MoCA): a screening tool for mild cognitive impairment and mild dementia in elderly. Dement Neuropsychol [Internet]. 2020; 14(2): 145-152. Disponible en: https://doi.org/10.1590/1980-57642020dn14-020007

Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini‐Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev [Internet]. 2021; (7): CD010783. Disponible en: https://doi.org/10.1002/14651858.CD010783.pub3

López-Álvarez J, Agüera-Ortiz LF. Nuevos criterios diagnósticos de la demencia y la enfermedad de Alzheimer: una visión desde la psicogeriatría. Psicogeriatría [Internet]. 2015; 5(1): 3-14. Disponible en: https://www.viguera.com/sepg/pdf/revista/0501/501_0003_0014.pdf

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology [Internet]. 1984; 34(7): 939-944. Disponible en: https://doi.org/10.1212/WNL.34.7.939

Sheehan B. Assessment scales in dementia. Ther Adv Neurol Disord [Internet]. 2012; 5(6): 349-358. Disponible en: https://doi.org/10.1177/1756285612455733

Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement [Internet]. 2013; 9(5): 529-537. Disponible en: https://doi.org/10.1016/j.jalz.2012.10.001

Published

2025-12-18

How to Cite

1.
Tinney N, Tafur Auqui RY, Jorge Marino GF, Meneses G. Validity of the Montreal Cognitive Assessment (MoCA) in older adults treated at an outpatient clinic in a hospital in Lima, Peru. Rev Neuropsiquiatr [Internet]. 2025 Dec. 18 [cited 2025 Dec. 21];88(4):335-41. Available from: https://revistas.upch.edu.pe/index.php/RNP/article/view/6358

Issue

Section

ORIGINAL ARTICLE